Defining an Acidosis-Based Ischemic Penumbra from pH-Weighted MRI

Translational Stroke Research

Volumn 3, Issue 1, 2012, Pages 76-83

  Zhou, Jinyuan ^a,b   van Zijl, Peter C M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Acidosis; APT; Area at risk of infarction; Ischemia; Ischemic threshold; MRI; Penumbra; Perfusion diffusion mismatch; pH Imaging; Salvageable tissue; Stroke

Indexed keywords

AMIDE; PROTON;

ACIDOSIS; ACUTE DISEASE; BRAIN ISCHEMIA; DIFFUSION WEIGHTED IMAGING; HUMAN; ISCHEMIA; ISCHEMIC PENUMBRA; NONHUMAN; PERFUSION WEIGHTED IMAGING; PH; PRIORITY JOURNAL; PROTON TRANSPORT; REVIEW; STROKE;

EID: 84857656352     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-011-0110-4     Document Type: Review

References (57)

1. World Health Organization. Available at http://gamapserver. who. int/gho/interactive_charts/mbd/cod_2008/graph. html.
2. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009; 8(3): 261-9.
3. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, et al. Acute stroke imaging research roadmap. Stroke. 2008; 39(5): 1621-8.
4. Astrup J. Thresholds of cerebral ischemia. In: Schmiedek P, editor. Microsurgery for stroke. Berlin: Springer; 1976. p. 16-21.
5. Baron JC, Marchal G. Ischemic core and penumbra in human stroke. Stroke. 1999; 30(5): 1150-3.
6. Heiss WD. The concept of the penumbra: can it be translated to stroke management? Int J Stroke. 2010; 5(4): 290-5.
7. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994; 36(4): 557-65.
8. Moseley ME, Sevick R, Wendland MF, White DL, Mintorovitch J, Asgari HS, et al. Ultrafast magnetic resonance imaging: diffusion and perfusion. Can Assoc Radiol J. 1991; 42(1): 31-8.
9. Moseley ME, Mintorovitch J, Cohen Y, Asgari HS, Derugin N, Norman D, et al. Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochir Suppl Wien. 1990; 51: 207-9.
10. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Modder U, et al. Diffusion-and perfusion-weighted MRI-the DWI/PWI mismatch region in acute stroke. Stroke. 1999; 30(8): 1591-7.
11. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000; 217(2): 331-45.
12. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab SF, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke. 2000; 31(6): 1318-28.
13. Schlaug G, Benfield A, Baird AE, Siewert B, Lovblad KO, Parker RA, et al. The ischemic penumbra-operationally defined by diffusion and perfusion MRI. Neurology. 1999; 53(7): 1528-37.
14. Wu O, Koroshetz WJ, Ostergaard L, Buonanno FS, Copen WA, Gonzalez RG, et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke. 2001; 32(4): 933-42.
15. Albers GW, Thijs VN, Wechsle L, Kemp S, Schlaug G, Skalabrin E, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurology. 2006; 60(5): 508-17.
16. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7(4): 299-309.
17. Kidwell CS, Alger JR, Saver JL. Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke. 2004; 35(11 Suppl 1): 2662-5.
18. Nicoli F, Lefur Y, Denis B, Ranjeva JP, Confort-Gouny S, Cozzone PJ. Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study. Stroke. 2003; 34(7): e82-7.
19. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke. 2005; 36(6): 1153-9.
20. Kakuda W, Lansberg MG, Thijs VN, Kemp SM, Bammer R, Wechsler LR, et al. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab. 2008; 28(5): 887-91.
21. Toth G, Albers GW. Use of MRI to estimate the therapeutic window in acute stroke: Is perfusion-weighted imaging/diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue? Stroke. 2009; 40(1): 333-5.
22. Wu O, Ostergaard L, Koroshetz WJ, Schwamm LH, O'Donnell J, Schaefer PW, et al. Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med. 2003; 50(4): 856-64.
23. Davis D, Ulatowski J, Eleff S, Izuta M, Mori S, Shungu D, et al. Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain. Magn Reson Med. 1994; 31(4): 454-60.
24. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke. 1992; 23(9): 1304-10. discussion 1310-1301.
25. Crockard HA, Gadian DG, Frackowiak RS, Proctor E, Allen K, Williams SR, et al. Acute cerebral ischaemia: concurrent changes in cerebral blood flow, energy metabolites, pH, and lactate measured with hydrogen clearance and 31P and 1H nuclear magnetic resonance spectroscopy. II. Changes during ischaemia. J Cereb Blood Flow Metab. 1987; 7(4): 394-402.
26. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med. 2003; 9(8): 1085-90.
27. Englander SW, Downer NW, Teitelbaum H. Hydrogen exchange. Annu Rev Biochem. 1972; 41: 903-24.
28. Wuthrich K. NMR of proteins and nucleic acids. New York: Wiley; 1986.
29. Mori S, Eleff SM, Pilatus U, Mori N, van Zijl PCM. Proton NMR spectroscopy of solvent-saturable resonance: a new approach to study pH effects in situ. Magn Reson Med. 1998; 40: 36-42.
30. van Zijl PCM, Zhou J, Mori N, Payen J, Mori S. Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med. 2003; 49: 440-9.
31. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson. 2000; 143: 79-87.
32. Zhou J, van Zijl PC. Chemical exchange saturation transfer imaging and spectroscopy. Progr NMR Spectr. 2006; 48: 109-36.
33. van Zijl PC, Yadav NN. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med. 2011; 65(4): 927-48.
34. Balaban RS, Ceckler TL. Magnetization transfer contrast in magnetic resonance imaging. Magn Reson Q. 1992; 8: 116-37.
35. Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: a review. NMR Biomed. 2001; 14: 57-64.
36. Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med. 2003; 50(6): 1120-6.
37. Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med. 2011; 17(1): 130-4.
38. Jokivarsi KT, Grohn HI, Grohn OH, Kauppinen RA. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia. Magn Reson Med. 2007; 57(4): 647-53.
39. Jokivarsi KT, Hiltunen Y, Tuunanen PI, Kauppinen RA, Grohn OH. Correlating tissue outcome with quantitative multiparametric MRI of acute cerebral ischemia in rats. J Cereb Blood Flow Metab. 2010; 30(2): 415-27.
40. Sun PZ, Murata Y, Lu J, Wang X, Lo EH, Sorensen AG. Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke. Magn Reson Med. 2008; 59(5): 1175-82.
41. Sun PZ, Zhou J, Sun W, Huang J, van Zijl PC. Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab. 2007; 27(6): 1129-36.
42. Shen Q, Meng X, Fisher M, Sotak CH, Duong TQ. Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J Cereb Blood Flow Metab. 2003; 23: 1479-88.
43. Katsura K, Asplund B, Ekholm A, Siesjo BK. Extra- and Intracellular pH in the brain during ischaemia, related to tissue lactate content in normo- and hypercapnic rats. Eur J Neurosci. 1992; 4(2): 166-76.
44. Allen K, Busza AL, Crockard HA, Frackowiak RS, Gadian DG, Proctor E, et al. Acute cerebral ischaemia: concurrent changes in cerebral blood flow, energy metabolites, pH, and lactate measured with hydrogen clearance and 31P and 1H nuclear magnetic resonance spectroscopy. III. Changes following ischaemia. J Cereb Blood Flow Metab. 1988; 8(6): 816-21.
45. Jones CK, Schlosser MJ, van Zijl PC, Pomper MG, Golay X, Zhou J. Amide proton transfer imaging of human brain tumors at 3 T. Magn Reson Med. 2006; 56(3): 585-92.
46. Schmitt B, Zaiß M, Zhou J, Bachert P. Optimization of pulse train presaturation for CEST imaging in clinical scanners. Magn Reson Med. 2011; 65: 1620-9.
47. Sun PZ, Wang E, Cheung JS, Zhang X, Benner T, Sorensen AG. Simulation and optimization of pulsed radio frequency irradiation scheme for chemical exchange saturation transfer (CEST) MRI-demonstration of pH-weighted pulsed-amide proton CEST MRI in an animal model of acute cerebral ischemia. Magn Reson Med. 2011; 66(4): 1042-8. doi: 10. 1002/mrm. 22894.
48. Zhao X, Wen Z, Huang F, Lu S, Wang X, Hu S, et al. Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med. 2011; 66(4): 1033-41. doi: 10. 1002/mrm. 22891.
49. Zhou J. Amide proton transfer imaging of the human brain. Methods Mol Biol. 2011; 711: 227-37.
50. Wen Z, Hu S, Huang F, Wang X, Guo L, Quan X, et al. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. NeuroImage. 2010; 51(2): 616-22.
51. Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, et al. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med. 2008; 60(4): 842-9.
52. Jia GA, Abaza R, Williams JD, Zynger DL, Zhou JY, Shah ZK, et al. Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging. 2011; 33(3): 647-54.
53. Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med. 2009; 61(6): 1441-50.
54. Sun PZ, Farrar CT, Sorensen AG. Correction for artifacts induced by B(0) and B(1) field inhomogeneities in pH-sensitive chemical exchange saturation transfer (CEST) imaging. Magn Reson Med. 2007; 58(6): 1207-15.
55. Dixon WT, Hancu I, Ratnakar SJ, Sherry AD, Lenkinski RE, Alsop DC. A multislice gradient echo pulse sequence for CEST imaging. Magn Reson Med. 2010; 63(1): 253-6.
56. Sun PZ, Cheung JS, Wang E, Benner T, Sorensen AG. Fast multislice pH-weighted chemical exchange saturation transfer (CEST) MRI with unevenly segmented RF irradiation. Magn Reson Med. 2011; 65(2): 588-94.
57. Zhu H, Jones CK, van Zijl PC, Barker PB, Zhou J. Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med. 2010; 64(3): 638-44.